A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
Clinical trial NCT05998928 · UNKNOWN
Trial details
- NCT number
- NCT05998928
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-27
- Primary completion
- 2025-07-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.